Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 1
2014 2
2015 5
2016 6
2017 4
2018 4
2019 6
2020 7
2021 4
2022 4
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
Rosso C, Kazankov K, Younes R, Esmaili S, Marietti M, Sacco M, Carli F, Gaggini M, Salomone F, Møller HJ, Abate ML, Vilstrup H, Gastaldelli A, George J, Grønbæk H, Bugianesi E. Rosso C, et al. Among authors: kazankov k. J Hepatol. 2019 Nov;71(5):1012-1021. doi: 10.1016/j.jhep.2019.06.031. Epub 2019 Jul 10. J Hepatol. 2019. PMID: 31301321 Free article.
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis.
Pose E, Solà E, Lozano JJ, Juanola A, Sidorova J, Zaccherini G, de Wit K, Uschner F, Tonon M, Kazankov K, Jiménez C, Campion D, Napoleone L, Ma AT, Carol M, Morales-Ruiz M, Alessandria C, Beuers U, Caraceni P, Francoz C, Durand F, Mookerjee RP, Trebicka J, Vargas V, Piano S, Watson H, Abraldes JG, Kamath PS, Davis MM, Ginès P; investigators of the LIVERHOPE Consortium. Pose E, et al. Among authors: kazankov k. Hepatol Commun. 2022 May;6(5):1100-1112. doi: 10.1002/hep4.1881. Epub 2021 Dec 28. Hepatol Commun. 2022. PMID: 34964311 Free PMC article. Clinical Trial.
Early normalization of reduced urea synthesis capacity after direct-acting antiviral therapy in hepatitis C cirrhosis.
Laursen TL, Sandahl TD, Kazankov K, Eriksen PL, Kristensen LH, Holmboe CH, Laursen AL, Vilstrup H, Grønbæk H. Laursen TL, et al. Among authors: kazankov k. Am J Physiol Gastrointest Liver Physiol. 2020 Aug 1;319(2):G151-G156. doi: 10.1152/ajpgi.00128.2020. Epub 2020 Jun 29. Am J Physiol Gastrointest Liver Physiol. 2020. PMID: 32597708 Free article.
Liver-related effects of chronic hepatitis C antiviral treatment.
Laursen TL, Sandahl TD, Kazankov K, George J, Grønbæk H. Laursen TL, et al. Among authors: kazankov k. World J Gastroenterol. 2020 Jun 14;26(22):2931-2947. doi: 10.3748/wjg.v26.i22.2931. World J Gastroenterol. 2020. PMID: 32587440 Free PMC article. Review.
[Non-alcoholic fatty liver disease in children and adolescents].
Björklund J, Laursen TL, Kazankov K, Thomsen KL, Hamilton-Dutoit S, Stenbøg E, Grønbæk H. Björklund J, et al. Among authors: kazankov k. Ugeskr Laeger. 2017 Jul 3;179(27):V11160796. Ugeskr Laeger. 2017. PMID: 28689548 Free article. Review. Danish.
Macrophage markers and innate immunity in cirrhosis.
Grønbæk H, Gantzel RH, Laursen TL, Kazankov K, Møller HJ. Grønbæk H, et al. Among authors: kazankov k. J Hepatol. 2020 Dec;73(6):1586-1588. doi: 10.1016/j.jhep.2020.07.033. Epub 2020 Sep 29. J Hepatol. 2020. PMID: 32994078 No abstract available.
41 results